Jason Ehrlich
Net worth: 325 720 $ as of 2024-03-30
Profile
Jason S. Ehrlich occupies the position of Chief Medical & Development Officer at Kodiak Sciences, Inc. In his past career Dr. Ehrlich occupied the position of Global Head-Clinical Ophthalmology at Genentech, Inc. He received an undergraduate degree from Princeton University and a doctorate from Stanford University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
KODIAK SCIENCES, INC.
0.12% | 2023-06-23 | 61,924 ( 0.12% ) | 325 720 $ | 2024-03-30 |
Former positions of Jason Ehrlich
| Companies | Position | End |
|---|---|---|
| KODIAK SCIENCES INC. | Chief Tech/Sci/R&D Officer | 2023-08-24 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2017-12-31 |
Training of Jason Ehrlich
| Princeton University | Undergraduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Kodiak Sciences, Inc. |
- Stock Market
- Insiders
- Jason Ehrlich
